Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Inventory (2019 - 2025)

Sunshine Biopharma (SBFM) has disclosed Inventory for 7 consecutive years, with $14.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Inventory rose 43.2% year-over-year to $14.1 million, compared with a TTM value of $14.1 million through Sep 2025, up 43.2%, and an annual FY2024 reading of $11.3 million, up 96.66% over the prior year.
  • Inventory was $14.1 million for Q3 2025 at Sunshine Biopharma, up from $13.0 million in the prior quarter.
  • Across five years, Inventory topped out at $14.1 million in Q3 2025 and bottomed at $26660.0 in Q1 2021.
  • Average Inventory over 5 years is $5.2 million, with a median of $4.3 million recorded in 2023.
  • The sharpest move saw Inventory skyrocketed 3014.0% in 2022, then soared 43.2% in 2025.
  • Year by year, Inventory stood at $105650.0 in 2021, then surged by 3014.0% to $3.3 million in 2022, then soared by 74.31% to $5.7 million in 2023, then surged by 96.66% to $11.3 million in 2024, then rose by 24.7% to $14.1 million in 2025.
  • Business Quant data shows Inventory for SBFM at $14.1 million in Q3 2025, $13.0 million in Q2 2025, and $11.9 million in Q1 2025.